You are here Home Resources and guidance Sponsors Shire Australia Pty Limited Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Australian public assessment report (AusPar) (1) Designation or determination (1) Date (-) 2019 (2) 2020 (1) 2018 (3) Search Filters applied:2019Clear all Sponsor content2 result(s) found, displaying 1 to 2 AusPAR: Icatibant (as acetate) 12 November 2019 Australian public assessment report (AusPar) Australian Public Assessment Report for Icatibant (as acetate) Notice for teduglutide (Shire Australia Pty Limited) 26 February 2019 Designation or determination Orphan drug
AusPAR: Icatibant (as acetate) 12 November 2019 Australian public assessment report (AusPar) Australian Public Assessment Report for Icatibant (as acetate)
Notice for teduglutide (Shire Australia Pty Limited) 26 February 2019 Designation or determination Orphan drug